Brought to you by

Lilly / 3M herpes deal is off
20 Oct 2003
Executive Summary
Eli Lilly & Co. and 3M Pharmaceuticals (a division of Minnesota Mining and Manufacturing) have entered into an agreement to collaborate on 3M's Phase III treatment for genital herpes, resiquimod.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Co-Promotion
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com